Feng ZB - Search Results

1

Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma.

Zhang R, Mo WJ, Huang LS, Chen JT, Wu WZ, He WY, Feng ZB. Zhang R, et al. Among authors: feng zb. Bioengineered. 2021 Dec;12(1):855-874. doi: 10.1080/21655979.2021.1890399. Bioengineered. 2021. PMID: 33641617 Free PMC article.

2

Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study.

Chen G, Dang YW, Luo DZ, Feng ZB, Tang XL. Chen G, et al. Among authors: feng zb. Oncol Res. 2008;17(4):183-9. doi: 10.3727/096504008785114138. Oncol Res. 2008. PMID: 18773863

3

[The clinical significance of cystatin B in hepatocellular carcinoma].

He J, Feng ZB, Wu MH. He J, et al. Among authors: feng zb. Zhonghua Gan Zang Bing Za Zhi. 2010 Dec;18(12):936-7. doi: 10.3760/cma.j.issn.1007-3418.2010.12.013. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 21205482 Chinese. No abstract available.

4

Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma.

Feng Z, Fan X, Jiao Y, Ban K. Feng Z, et al. Hum Pathol. 2011 May;42(5):659-68. doi: 10.1016/j.humpath.2010.07.021. Epub 2011 Jan 15. Hum Pathol. 2011. PMID: 21239045

5

Prognostic Value of Expression of Cyclin E in Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.

Huang L, Ren F, Tang R, Feng Z, Chen G. Huang L, et al. Technol Cancer Res Treat. 2016 Feb;15(1):12-9. doi: 10.1177/1533034614568098. Epub 2015 Jan 26. Technol Cancer Res Treat. 2016. PMID: 25627202 Free article. Review.

6

Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients.

Guo S, Chen W, Luo Y, Ren F, Zhong T, Rong M, Dang Y, Feng Z, Chen G. Guo S, et al. Int J Clin Exp Pathol. 2015 May 1;8(5):5395-402. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191242 Free PMC article.

7

Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.

Huang Z, Huang L, Shen S, Li J, Lu H, Mo W, Dang Y, Luo D, Chen G, Feng Z. Huang Z, et al. Oncol Rep. 2015 Nov;34(5):2403-12. doi: 10.3892/or.2015.4259. Epub 2015 Sep 8. Oncol Rep. 2015. PMID: 26352013

8

A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.

Xiong DD, Lv J, Wei KL, Feng ZB, Chen JT, Liu KC, Chen G, Luo DZ. Xiong DD, et al. Among authors: feng zb. Oncol Rep. 2017 Jun;37(6):3297-3304. doi: 10.3892/or.2017.5600. Epub 2017 Apr 25. Oncol Rep. 2017. PMID: 28440475

9

miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.

Shen SQ, Huang LS, Xiao XL, Zhu XF, Xiong DD, Cao XM, Wei KL, Chen G, Feng ZB. Shen SQ, et al. Among authors: feng zb. Oncol Rep. 2017 Jul;38(1):368-376. doi: 10.3892/or.2017.5644. Epub 2017 May 16. Oncol Rep. 2017. PMID: 28534958

10

Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.

Li CY, Pang YY, Yang H, Li J, Lu HX, Wang HL, Mo WJ, Huang LS, Feng ZB, Chen G. Li CY, et al. Among authors: feng zb. Am J Transl Res. 2017 May 15;9(5):2088-2105. eCollection 2017. Am J Transl Res. 2017. PMID: 28559963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters